Transcription of GLYCOPYRRONIUM BROMIDE 0.2MG/ML SOLUTION FOR …
{{id}} {{{paragraph}}}
Example: biology
GLYCOPYRRONIUM BROMIDE 0.2MG/ML SOLUTION FOR …
UKPAR GLYCOPYRRONIUM BROMIDE mg/ml SOLUTION for injection PL 00156 /0115. GLYCOPYRRONIUM BROMIDE SOLUTION FOR. injection (PL 00156 /0115). UKPAR. TABLE OF CONTENTS. Lay Summary Page 2. Scientific discussion Page 3. Steps taken for assessment Page 14. Steps taken after authorisation summary Page 15. Summary of Product Characteristics Product Information Leaflet Labelling 1. UKPAR GLYCOPYRRONIUM BROMIDE mg/ml SOLUTION for injection PL 00156 /0115. GLYCOPYRRONIUM BROMIDE SOLUTION FOR. injection (PL 00156 /0115). LAY SUMMARY. The MHRA today granted Martindale Pharmaceuticals Limited a Marketing Authorisation (licence) for the medicinal products GLYCOPYRRONIUM BROMIDE SOLUTION for injection (PL 00156 /0115). This is a prescription-only medicine (POM) used to (i) protect against some of the unwanted effects of drugs such as Neostigmine or Pyridostigmine (which reverse the effects of certain muscle-relaxing drugs); (ii) to reduce saliva and other secretions, and to reduce acidity in stomach contents before an operation; and (iii) to prevent slowness of the heartbeat during surgery.
UKPAR Glycopyrronium Bromide 0.2 mg/ml Solution for Injection PL 00156/0115 4 INTRODUCTION Based on the review of the data on quality, safety and efficacy, the UK granted a marketing
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: